RBC Capital on Cytokinetics (CYTK): 'The stock is significantly undervalued despite today's move' Jun 17, 2026 07:34AM
Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference May 12, 2026 04:00PM
Cytokinetics (CYTK) PT Raised to $119 at RBC Capital May 6, 2026 04:19AM
Cytokinetics (CYTK) PT Raised to $95 at RBC Capital Dec 22, 2025 06:44AM
Cytokinetics (CYTK) PT Raised at RBC Capital into Aficamten 2026 Launch Nov 11, 2025 08:38AM


Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Apr 30, 2025 04:00PM Cytokinetics to Participate in May Investor Conferences
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Dec 18, 2024 07:26AM Cytokinetics (CYTK) PT Raised to $82 at RBC Capital Following Bayer Partnership
Feb 14, 2018 04:00PM Cytokinetics to Present at the RBC Capital Markets Global Healthcare Conference
Feb 6, 2017 09:30AM Pre-Open Movers 02/06: (GALE) (HAS) (COG) Higher; (TIF) (IP) (BLUE) Lower (more...)
Jun 2, 2014 09:29AM Pre-Open Stock Movers 06/02: (NPSP) (PL) (BRCM) Higher; (PBYI) (MTZ) (CYTK) Lower (more...)
Apr 25, 2014 10:50AM Notable Analyst Rating Changes 04/25: (CELG) (SYNA) (WFC) Upgraded; (KLAC) (LLTC) (CYTK) Downgraded
Mar 5, 2014 10:50AM Notable Analyst Rating Changes 03/05: (P) (TRMB) (DST) Upgraded; (DDS) (SPLS) (PEI) Downgraded
Feb 7, 2014 09:32AM Pre-Open Stock Movers 2/7: (IMN) (LQDT) (EXPE) Higher; (FWM) (ELON) (LNKD) Lower (more...)
Nov 18, 2009 10:55AM Notable Analyst Rating Changes 11/18: SII, ZMH, FSLR, PHM Upgraded; TGT, ADSK, VIP, JEC, PARD Downgraded